ArticleClinical and translational science2021

Evaluation of drug-drug interaction potential between omecamtiv mecarbil and rosuvastatin, a BCRP substrate, with a clinical study in healthy subjects and using a physiologically-based pharmacokinetic model.

Ashit Trivedi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.